A phase 1 dose-escalation and -expansion study of AFN0328, a novel mRNA-based immunotherapy, in patients with HPV16/18-associated high-grade squamous intraepithelial lesions.

AFN0328 - Anhui Anke Biotech

https://www.asco.org/abstracts-presentations/268179

Yunxia Cao; Fengqiu Yao; Xiaoli Wang; Cheng Peng; Xiaohong Ruan; Da Chen; Lihua Song; Yucai Wang; Beicheng Sun; Ying Zhou; Yan Chen; Lin Liu; Yan Wang; Yunfang Yan; Li Ma; Xiuyun Zhang

Apr 21, 2026